Her primary areas of investigation include Neuroscience, Psychiatry, Internal medicine, Endocrinology and Extinction. The various areas that Victoria B. Risbrough examines in her Neuroscience study include Developmental psychology, Hydrochloride and Recall. Her research integrates issues of Cohort and Clinical psychology in her study of Psychiatry.
Her Internal medicine study combines topics from a wide range of disciplines, such as Oncology and DNA methylation. Her work deals with themes such as Receptor, Serotonin and Anxiogenic, which intersect with Endocrinology. The concepts of her Extinction study are interwoven with issues in Fear conditioning and Glucocorticoid receptor.
Victoria B. Risbrough mainly focuses on Internal medicine, Endocrinology, Neuroscience, Psychiatry and Clinical psychology. Victoria B. Risbrough has included themes like Schizophrenia, Prefrontal cortex and Oncology in her Internal medicine study. Her Endocrinology study incorporates themes from Agonist, Receptor, Anxiogenic, Pharmacology and Startle reaction.
Her Neuroscience research incorporates elements of Neurotransmission and Corticotropin-releasing hormone. Her Psychiatry study integrates concerns from other disciplines, such as Odds ratio and Startle response. Her Clinical psychology research includes themes of Mental health, Risk factor, Cohort and Anxiety.
Victoria B. Risbrough mostly deals with Internal medicine, Genetics, DNA methylation, Epigenetics and SNP. The Internal medicine study combines topics in areas such as Endocrinology, Oncology and Anxiety. Her work in the fields of Endocrinology, such as Amygdala and Fear conditioning, overlaps with other areas such as Kainate receptor.
Victoria B. Risbrough interconnects Cognitive psychology and Functional magnetic resonance imaging in the investigation of issues within Fear conditioning. Her Clinical psychology research is multidisciplinary, incorporating elements of Cohort study, Cohort and Anhedonia. She undertakes interdisciplinary study in the fields of Fatty acid amide hydrolase and Neuroscience through her works.
Victoria B. Risbrough mainly investigates Epigenetics, DNA methylation, Internal medicine, Oncology and SNP. In Epigenetics, Victoria B. Risbrough works on issues like Methylation, which are connected to Immune dysregulation and Meta-analysis. The study incorporates disciplines such as Traumatic brain injury and Epigenome in addition to Internal medicine.
As part of one scientific family, Victoria B. Risbrough deals mainly with the area of Heritability, narrowing it down to issues related to the Risk factor, and often Clinical psychology. Her study in the fields of Differentially methylated regions under the domain of Genetics overlaps with other disciplines such as Genome-wide association study. Her work in Locus addresses subjects such as Candidate gene, which are connected to disciplines such as Cohort.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Corticotropin Releasing Factor (CRF) Receptor Signaling in the Central Nervous System: New Molecular Targets
Richard L. Hauger;Victoria Risbrough;Olaf Brauns;Frank M. Dautzenberg.
Cns & Neurological Disorders-drug Targets (2006)
Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia.
Jared W. Young;Susan B. Powell;Victoria Risbrough;Hugh M. Marston.
Pharmacology & Therapeutics (2009)
Role of corticotropin releasing factor in anxiety disorders: a translational research perspective.
Victoria B. Risbrough;Murray B. Stein.
Hormones and Behavior (2006)
Role of CRF Receptor Signaling in Stress Vulnerability, Anxiety, and Depression
Richard L. Hauger;Victoria Risbrough;Robert H. Oakley;J. Alberto Olivares-Reyes.
Annals of the New York Academy of Sciences (2009)
Hippocampal dysfunction effects on context memory: possible etiology for posttraumatic stress disorder.
Dean T. Acheson;Jodi E. Gresack;Victoria B. Risbrough;Victoria B. Risbrough.
Pharmacological treatment of PTSD - established and new approaches.
Thomas Steckler;Victoria Risbrough;Victoria Risbrough.
A consideration of select pre-trauma factors as key vulnerabilities in PTSD
Jessica Bomyea;Victoria Risbrough;Victoria Risbrough;Ariel J. Lang;Ariel J. Lang.
Clinical Psychology Review (2012)
Genomic predictors of combat stress vulnerability and resilience in U.S. Marines: A genome-wide association study across multiple ancestries implicates PRTFDC1 as a potential PTSD gene.
Caroline M. Nievergelt;Caroline M. Nievergelt;Adam X. Maihofer;Maja Mustapic;Kate A. Yurgil.
Corticotropin-releasing factor receptors CRF1 and CRF2 exert both additive and opposing influences on defensive startle behavior.
Victoria B. Risbrough;Richard L. Hauger;Amanda L. Roberts;Wylie W. Vale.
The Journal of Neuroscience (2004)
Impaired Sensorimotor Gating in Unmedicated Adults with Obsessive–Compulsive Disorder
Susanne E Ahmari;Victoria B Risbrough;Mark A Geyer;H Blair Simpson.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: